Private Equity

With three international awards, Marina Pointe isn't just selling condos; it's cementing Tampa Bay's status as a premier global luxury destination.

Alto's ambitious high-speed rail plan is moving forward, with the Montréal-Ottawa line as its first phase. Public consultations are set to begin this month.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

Beyond a simple time change, Fortrea's upcoming JPM presentation is a critical test for its new CEO and a key moment to define its future in the CRO market.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A top luxury planner is trading Zoom calls for Swiss Alps adventures, letting couples "test-drive" their destination wedding before they say "I do."

ProMach's strategic purchase of AmHolt from Arcline signals a major push to dominate the packaging lifecycle, from new machines to critical aftermarket parts.

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

The value furniture giant is going public, revealing strong growth and ambitious expansion plans. Can its "Everyday Low Prices" model win over Wall Street?

Prescient's acquisition of Uptake creates an integrated giant in healthcare consulting. What does this mean for the industry, clients, and patient outcomes?

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

Private equity giant Platinum Equity invests in century-old Norton Packaging, signaling a major growth push in the resilient rigid packaging sector.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

With promising data in hard-to-treat cancers, iOnctura's lead drug, roginolisib, is set to make waves at the top healthcare investment forum.

The brokerage closed deals with 150 lenders in 2025, adding 48 new partners. How did this strategy help them navigate a complex real estate landscape?

With a massive $200M Series A and a promising Phase 2 drug, new biotech AirNexis aims to reshape the multi-billion dollar COPD treatment landscape.

Global investment giant Lone Star Funds acquires a second major office asset in South Florida, signaling strong confidence in the region's booming market.

Koppers Holdings navigates a key leadership change as CFO Jimmi Sue Smith retires. Veteran Bradley Pearce takes the helm as interim financial chief.

With a huge new investment, MEDIPOST is advancing its proven stem cell therapy for knee osteoarthritis into a pivotal Phase III trial in the United States.